Wenhui Jiao

Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

Zhe-Sheng Chen, M. Elkabets, Dexin Kong, 2021, Journal of Experimental & Clinical Cancer Research.

Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway.

Dexin Kong, Ran Wang, Shanwen Zhu, 2021, Life sciences.

ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair

Dexin Kong, Ran Wang, Shanwen Zhu, 2022, BioMed research international.

MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia.

Yun Bao, Y. Liu, Wenhui Jiao, 2019, European review for medical and pharmacological sciences.

Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

M. Elkabets, F. Claret, Ran Wang, 2021, Journal of Experimental & Clinical Cancer Research.

Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma

Shan Zhu, Dexin Kong, Ran Wang, 2019, Journal of Cancer Research and Clinical Oncology.

STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells.

Dexin Kong, Ran Wang, Xin Peng, 2021, Recent patents on anti-cancer drug discovery.